In the week of March 30, 2026, 28 holders filed a new Schedule 13D and 62 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated an intent to influence the company. The largest stake reported that week is Digital Investment Strategy LLC's 99.5% of Slam Corp. (Schedule 13D, April 1, 2026).
New 13D28
New 13G62
Stated intents1
The week of 2026-03-30, 28 holders filed a new Schedule 13D and 62 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-01 | Slam Corp. | Digital Investment Strategy LLC | 99.5% | SCHEDULE 13D |
| 2026-03-30 | Brookfield Business Partners LP | Brookfield Corporation | 69% | SCHEDULE 13D |
| 2026-04-02 | Xanadu Quantum Technologies Limited | Christian Weedbrook | 51.8% | SCHEDULE 13D |
| 2026-03-30 | CDT Equity Inc. | Taylor Mark Andrew | 43.79% | SCHEDULE 13D |
| 2026-04-03 | Capstone Energy+, Inc. | Monarch Alternative Capital LP | 42.1% | SCHEDULE 13D |
| 2026-04-03 | Eastern International Ltd. | Albert Wong | 39.9% | SCHEDULE 13D |
| 2026-03-31 | Horizon Quantum Holdings Ltd. | Joseph Francis Fitzsimons | 38.3% | SCHEDULE 13D |
| 2026-03-30 | Indaptus Therapeutics, Inc. | Yao Yun | 37.8% | SCHEDULE 13D |
| 2026-04-03 | Future Money Acquisition Corp | Future Wealth Capital Corp. | 29.36% | SCHEDULE 13D |
| 2026-03-31 | GalaxyEdge Acquisition Corp | Equinox Capital Solutions Limited | 27.39% | SCHEDULE 13D |
| 2026-04-03 | DarkIris Inc. | Hong Zhifang | 27.08% | SCHEDULE 13D |
| 2026-03-31 | Mistras Group, Inc. | Stephanie Foglia | 21.72% | SCHEDULE 13D |
| 2026-04-02 | Ibotta, Inc. | KDT Ibotta Holdings, LLC | 20.7% | SCHEDULE 13D |
| 2026-04-02 | Vivos Therapeutics, Inc. | V-Co Investors 3 LLC | 19.9% | SCHEDULE 13D |
| 2026-03-31 | Neuronetics, Inc. | Chernett Jorey | 14.12% | SCHEDULE 13D |
| 2026-04-01 | Horizon Quantum Holdings Ltd. | IonQ, Inc. | 13.3% | SCHEDULE 13D |
| 2026-04-01 | Leef Brands Inc. | Micah Payne Anderson | 12.2% | SCHEDULE 13D |
| 2026-04-03 | Phillips 66 | Link Co | 10% | SCHEDULE 13D |
| 2026-04-03 | Kraft Heinz Co | Link Co | 10% | SCHEDULE 13D |
| 2026-03-31 | ATA Creativity Global | Apollo Wise Investment Limited | 9.9% | SCHEDULE 13D |
| 2026-03-31 | URSB Bancorp, Inc. | Stilwell Joseph | 9.6% | SCHEDULE 13D |
| 2026-04-03 | Celularity Inc. | Philp & Daniele Barach Family Trust | 9.56% | SCHEDULE 13D |
| 2026-03-30 | SharonAI Holdings Inc. | James Edward Manning | 8.95% | SCHEDULE 13D |
| 2026-03-30 | Evotec SE | MAK Capital Fund LP | 7% | SCHEDULE 13D |
| 2026-04-01 | Alkami Technology, Inc. | Jana Partners Management, LP | 5.1% | SCHEDULE 13D |
| 2026-04-03 | Cyabra, Inc. | Yossef Daar | 5.1% | SCHEDULE 13D |
| 2026-04-03 | Cyabra, Inc. | Dan Brahmy | 5.1% | SCHEDULE 13D |
| 2026-04-03 | Cyabra, Inc. | Ido Shraga | 5.1% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-02 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 35.19% | SCHEDULE 13G |
| 2026-03-31 | D. Boral Acquisition I Corp. | David Boral | 31.02% | SCHEDULE 13G |
| 2026-04-02 | PRESIDIO PRODUCTION Co | EQV Ventures Sponsor LLC | 28.1% | SCHEDULE 13G |
| 2026-04-01 | Bluerock Acquisition Corp. | Bluerock Acquisition Holdings, LLC | 24.6% | SCHEDULE 13G |
| 2026-04-02 | Buda Juice, Inc. | Bernard Lucien Nussbaumer | 20.64% | SCHEDULE 13G |
| 2026-04-02 | Launchpad Cadenza Acquisition Corp I | Launch Sponsor LLC | 20% | SCHEDULE 13G |
| 2026-04-02 | Xanadu Quantum Technologies Limited | Dipender Saluja | 19.9% | SCHEDULE 13G |
| 2026-03-31 | Mistras Group, Inc. | Aspasia Vahaviolos | 19.32% | SCHEDULE 13G |
| 2026-04-02 | Buda Juice, Inc. | Bryan Herr | 18.79% | SCHEDULE 13G |
| 2026-04-01 | Black Rock Coffee Bar Inc | Samuel W. Weatherford | 16.3% | SCHEDULE 13G |
| 2026-04-02 | Buda Juice, Inc. | Horatio Lonsdale-Hands | 15.98% | SCHEDULE 13G |
| 2026-04-02 | Townsquare Media, Inc. | The Capital Management Corporation | 14.6% | SCHEDULE 13G |
| 2026-04-01 | ETF Opportunities Trust | Hahn Philip Lawrence Alexander | 13.7% | SCHEDULE 13G |
| 2026-03-31 | Nine Energy Service, Inc. | MacKay Shields LLC | 11.91% | SCHEDULE 13G |
| 2026-03-31 | Nine Energy Service, Inc. | MacKay Shields LLC | 11.91% | SCHEDULE 13G |
| 2026-04-01 | Sound Point Direct Lending BDC | Liberty Mutual Holding Company Inc. | 10.8% | SCHEDULE 13G |
| 2026-04-01 | Vor Biopharma Inc | Chen Yu | 10.5% | SCHEDULE 13G |
| 2026-03-30 | Cyabra, Inc. | Alpha Capital Anstalt | 9.99% | SCHEDULE 13G |
| 2026-04-01 | Aprea Therapeutics, Inc. | Soleus Private Equity Fund III, L.P. | 9.99% | SCHEDULE 13G |
| 2026-04-02 | Xanadu Quantum Technologies Limited | Bessemer Venture Partners XI Institutional L.P. | 9.99% | SCHEDULE 13G |
| 2026-04-03 | Artelo Biosciences, Inc. | Mitchell P. Kopin | 9.99% | SCHEDULE 13G |
| 2026-03-31 | Velos Acquisition I Corp. f/k/a M3-Brigade Acquisition V Corp. | Jain Global LLC | 9.9% | SCHEDULE 13G |
| 2026-03-31 | VCI Global Ltd | Esousa Group Holdings LLC | 9.9% | SCHEDULE 13G |
| 2026-04-02 | Karyopharm Therapeutics Inc. | RA Capital Management, L.P. | 9.9% | SCHEDULE 13G |
| 2026-04-02 | Karyopharm Therapeutics Inc. | Commodore Capital LP | 9.9% | SCHEDULE 13G |
| 2026-04-01 | OnKure Therapeutics, Inc. | Anders Hove | 9.5% | SCHEDULE 13G |
| 2026-03-31 | Sol-Gel Technologies Ltd | Great Point Partners, LLC | 8.45% | SCHEDULE 13G |
| 2026-04-01 | INVO Fertility, Inc. | Glenbrook Capital Management | 8.33% | SCHEDULE 13G |
| 2026-03-30 | Vertical Data Inc. | Nickel Jesse | 8.3% | SCHEDULE 13G |
| 2026-03-30 | Grabagun Digital Holdings Inc. | Cossey Brent | 8.3% | SCHEDULE 13G |
| 2026-04-03 | Signet Jewelers Ltd | Select Equity Group, L.P. | 8.1% | SCHEDULE 13G |
| 2026-04-03 | Vertical Aerospace Ltd. | Islet Management, LP | 7.33% | SCHEDULE 13G |
| 2026-04-01 | Cyabra, Inc. | Lowenstein Sandler Llp | 7.2% | SCHEDULE 13G |
| 2026-04-02 | Lands' End, Inc. | Lewhp, LLC | 7.2% | SCHEDULE 13G |
| 2026-03-31 | Almonty Inds Inc | Michael Lewis Black | 6.9% | SCHEDULE 13G |
| 2026-03-30 | Xencor Inc | RA Capital Management, L.P. | 6.5% | SCHEDULE 13G |
| 2026-04-02 | Future Money Acquisition Corp | Linden Advisors LP | 6.5% | SCHEDULE 13G |
| 2026-03-30 | Reviva Pharmaceuticals Holdi | Integrated Core Strategies (US) LLC | 6.2% | SCHEDULE 13G |
| 2026-04-01 | Maze Therapeutics, Inc. | Paradigm BioCapital Advisors LP | 6.1% | SCHEDULE 13G |
| 2026-04-01 | Qdro Acquisition Corp. | MMCAP International Inc. SPC | 6% | SCHEDULE 13G |
| 2026-04-03 | PAVmed Inc. | Kallman Craig | 6% | SCHEDULE 13G |
| 2026-04-01 | Inflection Point Acquisition Corp. VI | Linden Advisors LP | 5.9% | SCHEDULE 13G |
| 2026-03-30 | WeRide Inc. | Uber Technologies, Inc | 5.82% | SCHEDULE 13G |
| 2026-03-31 | Ridgepost Capital, Inc. | Caz Investments LP | 5.8% | SCHEDULE 13G |
| 2026-04-02 | Rezolve AI plc | Gonzalez Alejandro | 5.7% | SCHEDULE 13G |
| 2026-03-30 | Accendra Health Inc | Kevin M. Webb | 5.61% | SCHEDULE 13G |
| 2026-03-31 | Aeluma Inc | Perry George Herbert | 5.6% | SCHEDULE 13G |
| 2026-04-01 | UiPath, Inc. | Tetragon Financial Group Limited | 5.6% | SCHEDULE 13G |
| 2026-04-01 | Avalo Therapeutics Inc | Logos Global Management LP | 5.6% | SCHEDULE 13G |
| 2026-04-02 | Wix.com Ltd. | Millennium Management LLC | 5.2% | SCHEDULE 13G |
| 2026-04-02 | Transcat Inc | Ophir Asset Management Pty Ltd | 5.2% | SCHEDULE 13G |
| 2026-03-30 | Lovesac | Kanen Wealth Management LLC | 5.1% | SCHEDULE 13G |
| 2026-03-30 | Perma Fix Environmental Services Inc | HOLD Alapkezelo Zrt. | 5.1% | SCHEDULE 13G |
| 2026-04-01 | Inflection Point Acquisition Corp. VI | MMCAP International Inc. SPC | 5.1% | SCHEDULE 13G |
| 2026-04-01 | Warner Music Group Corp. | Darlington Partners Capital Management, LP | 5.1% | SCHEDULE 13G |
| 2026-04-03 | Lantern Pharma Inc. | Thomas A. Satterfield, Jr. | 5.1% | SCHEDULE 13G |
| 2026-04-02 | Target Hospitality Corp. | Private Capital Management, LLC | 5.09% | SCHEDULE 13G |
| 2026-03-31 | Chatham Lodging Trust | Sculptor Real Estate Advisors LP | 5.01% | SCHEDULE 13G |
| 2026-03-31 | First Watch Restaurant Group Inc | Integrated Core Strategies (US) LLC | 5% | SCHEDULE 13G |
| 2026-04-01 | Omnicell, Inc. | Millennium Management LLC | 5% | SCHEDULE 13G |
| 2026-04-01 | Vericel Corp | Soleus Capital Master Fund, L.P. | 5% | SCHEDULE 13G |
| 2026-04-01 | Centerspace | Voss Capital, LP | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-03-31 | Sturm Ruger & Co Inc | Beretta Holding S.A. intent stated | 9.95% | SCHEDULE 13D/A |
Download this data (CSV)91 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.